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9 Abstract
10 Background: Production of cassava (Manihot esculenta Crantz), a food security crop in sub-Saharan Africa, is
11 threatened by the spread of cassava brown streak disease (CBSD) which manifests in part as a corky necrosis in the
12 storage root. It is caused by either of two virus species, Cassava brown streak virus (CBSV) and Ugandan cassava
13 brown streak virus (UCBSV), resulting in up to 100% yield loss in susceptible varieties.
14 Methods: This study characterized the response of 11 cassava varieties according to CBSD symptom expression
15 and relative CBSV and UCBSV load in a field trial in Uganda. Relative viral load was measured using quantitative
16 RT-PCR using COX as an internal housekeeping gene.
17 Results: A complex situation was revealed with indications of different resistance mechanisms that restrict virus
18 accumulation and symptom expression. Four response categories were defined. Symptom expression was not
19 always positively correlated with virus load. Substantially different levels of the virus species were found in many
20 genotypes suggesting either resistance to one virus species or the other, or some form of interaction, antagonism
21 or competition between virus species.
22 Conclusions: A substantial amount of research still needs to be undertaken to fully understand the mechanism and
23 genetic bases of resistance. This information will be useful in informing breeding strategies and restricting virus spread.
24
Keywords: Cassava, Cassava brown streak viruses, Resistance mechanism, Virus accumulation
25 Background
26 Cassava brown streak disease (CBSD) has been identified
27 among the seven most serious threats to world food
28 security [1]. Leaf symptoms include blotchy yellow
29 chlorosis or feathery necrosis, often associated with
30 minor veins, which can appear within the first few
31 months after planting of infected cuttings and persist in
32 mature leaves. Brown, round or elongate streak-like
33 lesions can occur on the young green portion of infected
34 stems, but the main economic loss is caused by dry,
35 brown necrotic lesions in the storage tissues of the
36 tuberous roots of infected susceptible plants [2-4]. Root
37 constrictions are also sometimes observed as well as
38 brown/black lesions on green fruits, and necrotic lesions
39in leaf scars. In severe infections these lesions develop to
40kill the dormant axilliary buds leading to a general
41shrinkage of the node and death of the intermodal
42tissue, so that the branch dies from the tip to cause
43‘dieback’ [5]. Secondary losses occur as a consequence
44of early harvesting, which farmers use as a strategy to
45avoid root necrosis [6].
46CBSD is caused by at least two distinct virus species;
47Cassava brown streak virus (CBSV), and Uganda
48cassava brown streak virus (UCBSV), both picorna-like
49(+) ssRNA viruses from the genus Ipomovirus, family
50Potyviridae [7,8]. These viruses spread along with
51the infected vegetative planting material and are also
52transmitted in a semi-persistent manner by whitefly,
53Bemisia tabaci [9]. For the first approximately 70 years
54that CBSD was recognized [2] it occurred at relatively low
55levels in coastal East Africa, from Mozambique in the south* Correspondence: m.ferguson@cgiar.org3International Institute of Tropical Agriculture (IITA), c/o ILRI, P.O Box 30709,
Nairobi 00100, Kenya
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56 to north-eastern Kenya in the north, and inland to the
57 shores of Lake Malawi [3,5]. In the early 2000s, however,
58 new outbreaks were reported from south-central Uganda
59 [10], western Kenya (H.M. Obiero, personal communi-
60 cation) and north-western Tanzania [11]. More recently
61 CBSD has been reported from Burundi [12], Rwanda [13]
62 and the Democratic Republic of Congo [14], indicating
63 a possible spread to West Africa. The spread of CBSVs
64 has been fuelled by so-called ‘super-abundant’ whiteflies,
65 Bemisia tabaci [4,15].
66 Breeding for resistance to cassava mosaic disease (CMD)
67 and CBSD was initiated in 1937 in Amani, Tanzania and
68 due to insufficient levels of resistance in cultivated cassava,
69 a strategy to incorporate resistance from wild species,
70 particularly from M. glaziovii and M. melanobasis (now
71 regarded as M. esculenta subsp. flabellifolia [16]), through
72 inter-specific hybridization and backcrossing was adopted
73 [17,18]. Several of these inter-specific hybrids have been
74 incorporated into the farming systems in the region and are
75 now considered as ‘farmer varieties’ or landraces. One of
76 the most resistant of these is known as ‘Kaleso’ in Kenya
77 and ‘Namikonga’ in Tanzania [5,19]. Today these form an
78 important genepool for CBSD resistance breeding and
79 some of the genotypes used in this study are derived from
80 the Amani breeding program.
81 Severity of CBSD symptom expression varies considerably
82 with cassava varieties and with the environment [5,18].
83 Some varieties show severe shoot and root symptoms while
84 others show either marked leaf symptoms and mild root
85 necrosis or visa versa, as well as combinations of milder
86 versions of both leaf and root symptoms [5,20]. Recent
87 evidence from a graft-innoculated cassava glasshouse
88study showed that ‘resistant’ and ‘tolerant’ varieties, with
89mild symptoms, restrict virus accumulation in the plant
90and support lower virus titres than susceptible geno-
91types [21]. This supports the findings of others [22] and
92suggests that ‘tolerant’ varieties possess molecular re-
93sistance mechanisms that impair the replication of
94CBSVs. Although different levels of resistance/tolerance
95are recognized, no immunity has been observed. In this
96study genotypes were systematically evaluated under
97field conditions to quantify their response to virus infec-
98tion and determine the relationship between relative
99virus load, symptom type and severity.
100Results
101CBSD shoot symptom severity and incidence
102Genotypes NASE 14, NASE 1, Kiroba and NASE 19 did
103not show shoot symptoms during the duration of the
104experiment (Table T11). Of those genotypes that showed
105symptoms, Namikonga and TZ/130 had the lowest mean
106incidence of 9% and 17% and mean shoot severity of
1071.09 and 1.17 respectively, while known CBSD suscep-
108tible varieties, Albert and TME 204, showed severe shoot
109symptoms with mean shoot severity of 3 and 4.07 re-
110spectively and mean incidence of 100% (Table 1). Shoot
111symptoms that were observed as early as 3MAP per-
112sisted up to the time of harvest (Figure F11). Maximum
113CBSD shoot symptom incidence was observed at 5MAP
114in genotypes TZ/130 and NDL06/132, while in other
115genotypes such as Albert and AR40-6, the disease inci-
116dence continued to rise after 5MAP (Figure 1). Higher
117abscission was noted among the lower leaves on which
118symptoms predominate.
t1:1 Table 1 Shoot and root CBSD symptom incidence and severity, coefficient of determination (r2) between virus load
t1:2 and mean shoot symptom expression, and harvest index
t1:3 Genotype Shoot incidence
% (9MAP)
Shoot symptom
severity (9MAP)
Root necrosis
incidence %
Root necrosis
severity
Coefficient of determination
(r2) between virus titre and
mean shoot symptoms at
3,5,7,9 and 11MAP
Harvest
index
t1:4 Mean SD* Min Max Mean SD* Min Max UCBSV CBSV
t1:5 NASE 14 0 1.00 0.00 1 1 31.7 1.35 0.88 1 5 - - 0.37
t1:6 Kiroba 0 1.00 0.00 1 1 14.3 1.07 0.12 1 3 - - 0.36
t1:7 NASE 1 0 1.00 0.00 1 1 18.0 1.05 0.09 1 2 - - 0.35
t1:8 NASE 19 0 1.00 0.00 1 1 67.0 2.15 1.52 1 5 - - 0.26
t1:9 Namikonga 9 1.09 0.30 1 2 10.0 1.03 0.04 1 2 0.37 0.67 0.15
t1:10 TZ/130 17 1.17 0.39 1 2 38.3 1.20 0.67 1 4 0.17 0.33 0.44
t1:11 AR40-6 52 1.61 0.58 1 3 30.3 1.09 0.28 1 3 0.16 0.97 0.49
t1:12 Kibaha 75 2.25 0.89 1 3 67.4 2.75 1.00 3 5 0.93 0.35 0.37
t1:13 NDL06/132 67 2.30 1.53 1 4 39.7 1.53 0.40 2 3 0.92 0.67 0.49
t1:14 Albert 100 3.00 0.00 3 3 66.3 2.54 1.23 1 5 0.96 0.52 0.29
t1:15 TME 204 100 4.07 0.55 3 5 100 4.78 0.39 4 5 0.84 0.53 0.16
t1:16 *SD – Standard deviation,
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119 CBSD root symptom severity and incidence
120 One of six Namikonga plants showed the mildest of
121 symptoms (Class 2) (Tables 1 andT2 2). It had the highest
122 proportion of plants with no root necrosis (83.3%),
123 followed by NASE 1 and AR40-6 with 73.3% and
124 63.6% respectively (Table 2). All plants in NDL06/132,
125 Kibaha and TME 204 showed at least one root with
126 root necrosis. Seven Kibaha and 10 TME 204 plants
127 showed symptoms with a maximum score of 5. Namikonga
128 and NASE 1 had a maximum root necrosis severity
129 score of 2, while AR40-6, Kiroba and NDL06/132 scored
130 3 and TME 204, Albert, Kibaha and NASE 14 all scored 5
131 (Table 1).
132 Interestingly 15 of NASE 14 plants were asymptomatic
133 for both shoot and root symptoms, five showed mild
134 symptoms and two showed very high severity (4 or 5)
135 and incidence (90–100) on roots. This was coupled with
136 reduction in growth and in some cases dieback.
137Detection and quantification of UCBSV and CBSV
138Both UCBSV and CBSV were detected in all varieties at
139some stage during the growing season. None of the
140varieties were immune. Amplification plots are shown
141in Figure F22 at 11MAP for CBSV, USBSV and COX.
142CBSV was detected at 3MAP in all varieties except
143Kiroba, Kibaha, Namikonga and NASE19, which showed
144infection at 5MAP (Table T33). Similarly UCBSV was detected
145in all varieties except Kiroba, NASE 1 and Kibaha. However
146by 5MAP, UCBSV could be detected in all varieties except
147NASE1 which started showing infection by 9MAP (Table 3).
148Interestingly, after detection at 5 and 7MAP, UCBSV was
149undetectable in Kiroba 9 and 11MAP. Absolute Ct values of
150both UCBSV and CBSV observed in the selected genotypes
151at 3,5,7,9 and 11 MAP are presented in Additional file 1:
152Tables S1 and S2.
153Though both virus species were detected in all the geno-
154types, the viral load differed among genotypes. At the final
Figure 1 CBSD shoot incidence in selected genotypes with time.
t2:1 Table 2 Number of plants per variety with plant root mean disease incidence in a given range
t2:2 Genotypes Number of plants showing per
plant mean root disease incidence
Total number of plants
assessed per genotype
Total number of roots
assessed per genotype
% symptomless
plants
t2:3 0% 1-5% 6-25% 26-75% >75%
t2:4 NASE 14 7 5 1 1 1 15 114 46.7
t2:5 Kiroba 3 3 1 0 0 7 54 42.9
t2:6 NASE 1 11 3 1 0 0 15 72 73.3
t2:7 NASE 19 2 2 0 1 4 9 82 22.2
t2:8 Namikonga 5 1 0 0 0 6 37 83.3
t2:9 TZ/130 11 4 3 1 1 20 164 55
t2:10 AR40-6 14 6 2 0 0 20 164 63.6
t2:11 Kibaha 0 0 2 2 3 7 60 0
t2:12 NDL06/132 0 2 2 0 2 6 73 0
t2:13 Albert 1 3 5 2 9 20 93 5
t2:14 TME 204 0 0 0 0 10 10 34 0
Kaweesi et al. Virology Journal 2014, 11:216 Page 3 of 14
http://www.virologyj.com/content/11/1/216
155 sampling time-point (11MAP), genotype NASE 14, had the
156 least relative viral load for both UCBSV and CBSV i.e. 1.16
157 and 0.00071 folds (ΔΔCt), respectively (TableT4 4). As the fold
158 change at 5,7,9 and 11 MAP is calculated relative to the
159 ΔCt value at 3MAP, and since CBSV was detected at 3
160 MAP (Ct values of the technical reps were 21.32 and 23.86
161 (Additional file 1: Table S2), the value of 0.00071 indicates
162 that the virus was present but there was little if any change
163 in virus load relative to 3MAP, taking into consideration
164the small variations in Ct values of the internal controls.
165Other genotypes with comparatively low virus titre for
166UCBSV included Kiroba (0.7), AR40-6 (0.026), TZ/130
167(1.72), Namikonga (9.25) and NASE 19 (16.11). Genotype
168NDL06/132 had the highest relative UCBSV viral load
169(353169.2). For CBSV, Kiroba, NASE 19 and Namikonga
170also had comparatively low relative viral loads of 30.1, 165.4
171and 199.5 folds respectively. Genotype NDL06/132 had the
172highest virus titre of 294927.33 folds (Table 4).
ba 
c 
Figure 2 Amplification plots at 11MAP for (a) CBSV, (b) UCBSV and (c) COX, the housekeeping gene. From the amplification plot, the Ct values
for CBSV in most genotypes were detected earlier (a) and showed exponential increase as compared to those of UCBSV (b) in the same genotypes.
Legend represents different genotypes: NASE 14 (A), AR40-6 (B), Kibaha (C), NDL06/132, Kiroba (E), Albert (F) and non-template control (G).
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173 In most cases the relative concentration of CBSV
174 was significantly higher than that of UCBSV; for
175 example the CBSV concentration in TZ/130 and AR40-6
176 were 143431.3 and 294927.33 folds respectively, compared
177 to 1.72 and 0.026 folds respectively for UCBSV. However,
178it is noted that genotypes Kibaha and NDL06/132
179had higher relative virus loads for UCBSV than CBSV,
180although in these cases titres for both viruses were
181high (Table 4).
182Table 4 and Figure F33 show the progression of relative
183virus titre for CBSV and UCBSV from 5, 7 and 9 to
18411MAP. All genotypes showed an increase in UCBSV
185titre between 3 – 7MAP, with the titre in the susceptible
186checks, Albert and TME 204 increasing dramatically at
1879MAP, and continued to increase at a slower rate at
18811MAP. In addition the concentration of UCBSV in
189NDL06/132, previously thought to be tolerant to CBSD
190increased substantially after 7MAP. Relative titres of
191UCBSV also increased in Kibaha although at much lower
192levels. After 7MAP the relative virus load of NASE 1
193and NASE 19 also increased, but at much lower levels
194(132 fold and 10.57 folds respectively). UCBSV titre in
195NASE 14 and Kiroba continued to drop to 11MAP,
196but that in Namikonga rose slightly from 7 to 11MAP. In
197fact UCBSV could not be detected in Kiroba from 9
198to 11 MAP. TZ/130 maintained a steady low virus
199load from 7 to 11MAP.
200In general virus loads were much higher for CBSV
201than UCBSV. For CBSV, virus load rose in all genotypes,
202except Albert, up to 7 MAP (Table 4 and Figure 3). This
203was however at different levels and five different profiles
204were observed. CBSV loads were low at 5 MAP in
205Kiroba and NASE 14 and were also low at 11 MAP,
206however levels in NASE 14 remained low throughout
207whereas there was a peak in levels at 9 MAP (16,270)
208in Kiroba. Here, the consistently low levels of virus
209are termed CBSV Profile 1. In Namikonga virus load
210rose to quite high levels (153,725) at 7 MAP but then
211fell dramatically to 11MAP (199). A similar profile
212was observed in NASE 1, however the virus did not
213drop to such low levels (133,826). A drop in virus
t3:1 Table 3 Detection (presence/absence) of CBSV and UCBSV in the selected genotypes during the course of the infection
t3:2 Genotype 3MAP 5MAP 7MAP 9MAP 11MAP
t3:3 UCBSV CBSV UCBSV CBSV UCBSV CBSV UCBSV CBSV UCBSV CBSV
t3:4 NASE 14 + + + + + + + + + +
t3:5 Kiroba _ _ + + + + _ + _ +
t3:6 NASE 19 + _ + + + + + + + +
t3:7 Namikonga + _ + + + + + + + +
t3:8 TZ/130 + + + + + + + + + +
t3:9 NASE 1 _ + _ + _ + + + + +
t3:10 Kibaha _ _ + + + + + + + +
t3:11 Albert + + + + + + + + + +
t3:12 AR40-6 + + + + + + + + + +
t3:13 NDL06/132 + + + + + + + + + +
t3:14 TME 204 + + + + + + + + + +
t3:15 + pooled sample tested positive for the virus; − pooled sample tested negative for the virus.
t4:1 Table 4 Accumulation of UCBSV and CBSV in selected
t4:2 genotypes with time (fold change relative to 3MAP, ΔΔCt)
t4:3 Genotypes 5 MAP 7 MAP 9MAP 11 MAP
t4:4 UCBSV
t4:5 Namikonga 1.67 3.81 1.87 9.25
t4:6 NASE 1 1.18 1.39 1.75 133.4
t4:7 AR40-6 8.88 63.12 588.13 0.026
t4:8 Kiroba 24.59 76.64 36.76 0.7
t4:9 Tz/130 0.49 1.96 1.09 1.72
t4:10 NASE 14 1.77 58.48 2.08 1.16
t4:11 NASE 19 2.00 5.54 6.41 16.11
t4:12 NDL06/132 22.94 48.17 2836.7 353169.2
t4:13 Albert 3.66 6.19 20738.2 220435.95
t4:14 Kibaha 32.45 105.42 407.31 5634.21
t4:15 TME 204 4039.61 279018.26 912838.43 2039805.3
t4:16 CBSV
t4:17 Namikonga 7804.01 153725.82 568.1 199.5
t4:18 NASE 1 205.07 606437.70 15608.02 133826.1
t4:19 AR40-6 9.45 95.01 224.41 294927.33
t4:20 Kiroba 53.44 709.18 16270.8 30.1
t4:21 Tz/130 76331.98 499456.67 236257.4 143431.3
t4:22 NASE 14 6.25 86.22 0.008 0.00071
t4:23 NASE 19 129.79 552.56 1287.18 165.42
t4:24 NDL06/132 38165.99 1503611.1 294927.33 297978.71
t4:25 Albert 32995.91 20425 110217.9 148489.36
t4:26 Kibaha 1296.13 11113.30 426442.37 2836.44
t4:27 TME 204 82952.6 945029.61 102837.01 318293.9
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214 load at 7MAP is termed CBSV Profile 2. In NASE 19 and
215 Kibaha CBSV levels rose to 9 MAP, then dropped to
216 11MAP. This is known as CBSV Profile 3. In AR40-6,
217 levels started fairly low at 5MAP but then rose steadily to
218 11 MAP (294,927) (CBSV Profile 4). Levels of virus were
219 high throughout in Albert, Tz130, NDL06/132 and
220 TME204 (CBSV Profile 5).
221 Correlation of virus load with symptom expression
222 For varieties showing shoot symptoms the correlation of
223 determination (r2) was calculated between log10 of the
224 virus titre fold change and mean shoot symptom score
225 at 3,5,7,9 and 11MAP (FigureF4 4, Table 1). A strong posi-
226 tive r2 value was observed for Kibaha (0.93), Albert
227 (0.96) and NDL06/132 (0.92) for UCBSV and AR40-6
228 (0.97) for CBSV. Weak relationships and low r2 values
229 were obtained for TZ/130 (0.17) and AR40-6 (0.16)
230 for UCBSV and for TZ/130 (0.33) and Kibaha (0.35)
231 for CBSV. In terms of root necrosis and log10 fold
232 change in virus titre, Namikonga and to some extent
233Kiroba both had relatively low virus loads and root
234necrosis incidence and severity. NASE 14 and NASE
23519 had low virus titres but high root necrosis incidence
236(31.7% and 67% respectively) and severity (both with
237maximum scores of 5). NASE 1 on the other hand
238had a high relative virus load of 133826 for CBSV at
23911MAP but no shoot symptoms and a root necrosis
240incidence of 18% with a mean severity score of 1.05
241and maximum of 2 (Table 1).
242Yield performance of the test genotypes at NaCRRI
243Harvest index was used as an indirect assessment
244for fresh root yield. There was substantial variation
245in harvest index among the screened genotypes ran-
246ging from 0.15 – 0.49 (Table 1). Genotypes AR40–6
247and NDL06/132 had the highest harvest index of
2480.49, followed by TZ/130 and Kiroba with 0.46 and
2490.39 respectively, while NASE 19 and Namikonga had
250significantly low values of harvest index of 0.26 and
2510.15 respectively.
Figure 3 Accumulation of both UCBSV (A, C and E) and CBSV (B, D and F) with time.
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Figure 4 Association between virus titre and CBSD shoot symptom development in selected cassava genotypes at 3, 5, 7, 9, and 11 MAP.
A) UCBSV in Kibaha, B) CBSV in Kibaha, C) UCBSV in AR40-6, D) CBSV in AR40-6, E) UCBSV in Albert, F) CBSV in Albert, G) UCBSV in NDL06/132 and
H) CBSV in NDL06/132.
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252 Discussion
253 CBSD is a major constraint to cassava production in
254 southern and eastern Africa, and threatens this carbohy-
255 drate staple in Central and West Africa. Continent-wide
256 strategies are being developed to restrict the spread of
257 the virus, including diagnostics and surveillance, preven-
258 tion and control of infection using phytosanitation, and
259 control of disease through the breeding and promotion of
260 varieties that inhibit virus replication and/or movement
261 [15]. Currently there is very little known about relative
262 virus loads in field resistant/tolerant and susceptible germ-
263 plasm. Even less is known about the interaction and rela-
264 tive competitiveness between UCBSV and CBSV in dual
265 infections. Understanding cultivar response in relation to
266 these aspects is important if appropriate control measures
267 based on breeding are to be implemented, to restrict the
268 spread of the virus. It is important that newly released
269 varieties are either immune to the virus or restrict virus
270 accumulation and harbor low virus load. This will reduce
271 the source of inoculum and restrict the spread of the virus.
272 Although a number of studies have been performed under
273 glasshouse conditions using artificial inoculation [21-23],
274 few field based studies have been reported under natural
275 infection. Here we investigate symptom expression and
276 CBSV and UCBSV relative loads over time under field
277 conditions in 11 cassava varieties, eight of which have
278 been classified as tolerant or resistant to CBSD in Uganda
279 and/or Tanzania based on symptom incidence and severity
280 in the field. It is anticipated that this type of analysis will
281 be standardized and mainstreamed in cassava breeding.
282 CBSD tolerant materials were sourced from breeding
283 programs in Tanzania (AR40-6, NDL06/132, Kiroba and
284 Namikonga), Uganda (NASE 1, NASE 14, NASE 19 and
285 TZ/130) and The International Institute of Tropical
286 Agriculture, Nigeria, (TME 204). The experiment was
287 conducted with virus-free cassava stakes over 12 months.
288 None of the varieties tested were immune to CBSV or
289 UCBSV. Mixed infection of both UCBSV and CBSV was
290 evident in all cassava genotypes. Genotypes varied in
291 symptom expression and relative virus load of UCBSV and
292 CBSV which also varied over time, indicating differential
293 genotype response to virus infection.
294 Shoot symptoms
295 In accordance with previous work [5] considerable variation
296 was observed in incidence and severity of shoot symptoms.
297 No shoot symptoms were observed in Kiroba, NASE 1,
298 NASE14 and NASE19 yet 100% incidence was observed in
299 Albert and TME 204 which also showed mean severities of
300 3 and 4.07 respectively. In many cases there was a positive
301 relationship between shoot incidence and severity and root
302 necrosis incidence and severity. A few exceptions included
303 genotype NASE 19 which had no shoot symptoms, but root
304 necrosis incidence of 67% with a maximum of 5. Reasons
305for this disparity remain unclear although [24] reported
306the possibility of localization of the virus in the base
307of the plant.
308To date the focus in breeding has been on reducing
309roots necrosis, and the expression of shoot symptoms
310has been considered acceptable if root symptoms are
311absent, infrequent or very mild [25]. However [26] indi-
312cated that yield reductions resulting from shoot symptoms
313could be larger than losses due to root necrosis. This
314suggests that future cassava breeding should incorporate
315selection for reduced shoot incidence and symptoms [25].
316Root necrosis
317Variation in root necrosis was observed as expected and
318was consistent with previous observations of CBSD [5].
319Namikonga, NASE1 and Kiroba had an incidence of root
320necrosis less than 20%, and maximum severity scores of
3212, 2 and 3 respectively. AR40-6 had an incidence of
32230.3%, but a mean severity score of 1.09 and a maximum
323of 3. It is likely that these genotypes possess elements
324that will be useful in a CBSD resistance breeding, but
325these must be considered in relation to virus load. In
326three different studies Namikonga, also known as Kaleso,
327showed the highest general combining ability for resistance
328to CBSD [27-29]. This cultivar is now widely used by
329national breeding programs in the region.
330Interestingly NASE14 remained asymptomatic for CBSD
331for both shoot and roots while the few that succumbed to
332infection showed very high root severity (4 or 5) and inci-
333dence (90 -100%). This was coupled with reduction in
334growth and in some cases dieback. This response will have
335to be confirmed through fingerprinting of individual plants
336to ensure uniformity in genotype and diagnostics on indi-
337vidual plants to dismiss the possibility of ‘escapes’. It can be
338hypothesized that there could be a threshold at which the
339virus overcomes the plant defense mechanism thereby
340causing necrosis. This hypothesis should be further investi-
341gated in ‘degeneration’ trials. Such studies will be important
342in determining resistance durability and in designing seed
343systems for cassava planting materials. Similarly derivatives
344of M. melanobasis (now regarded as M. esculenta subsp.
345flabellifolia [16]), were observed to be highly resistant and
346rarely became diseased but, when present, the symptoms
347were severe [18]. This was attributed to a low capacity to
348recover from symptoms with new symptom-free growth.
349Detection and quantification of (U)CBSV
350The large differences in virus load of UCBSV (low) and
351CBSV (high) in TZ/130, AR40-6 and NASE 1 could be due
352to competition among the viruses with CBSV outcom-
353peting UCBSV, differences in pathogenicity or differential
354reaction of genotype to each virus. Higher virus loads of
355epidemic CBSV than endemic UCBSV in cassava varieties
356and herbaceous hosts have been observed previously [30],
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357 greater transmission rates [30,21] and more severe symp-
358 toms [8,30]. Due to lack of information regarding inter-
359 action of the viruses and their relative competitiveness, the
360 two virus species were both considered together here, and
361 no inferences made on whether a genotype was resistant
362 or susceptible to either virus.
363 Relative virus loads changed through the growing season
364 with NASE 14 and Namikonga showing a decline in
365 relative UCBSV and CBSV loads at 7MAP and Kiroba
366 at 7MAP and 9MAP respectively. Kiroba had tested
367 positive for UCBSV at 5 and 7MAP but this could
368 not be detected at 9 and 11MAP (Table 3, Figure 3).
369 A similar situation was observed in Kaleso (equivalent to
370 Namikonga) and Kiroba in the middle of an infection time
371 course experiment [9]. Declines were also observed in
372 AR40-6 (UCBSV) and NASE 1 (CBSV). This phenomenon
373 indicates either competition among viruses (eg. AR40-6)
374 and/or activation of an antiviral defense system, which
375 could include RNA interference [31]. The fact that this
376 mechanism allows the virus to accumulate in the plant for
377 some time before it is reduced means that this mechanism
378 is not constitutive, but inducible. Recovery has been
379 observed during periods of rapid growth (9 to 15MAP)
380 [32,18] but it is yet to be determined whether this recovery
381 coincides with reduction in virus load. In addition, it
382 would be interesting to observe the dynamics of virus load
383 if infected cuttings were used, or in ‘degeneration’ trials,
384 as observations may be specific to newly infected cuttings.
385 Correlation of virus load with symptom expression
386 Symptom expression has been shown to correlate with
387 virus load in different organs of two genotypes [22]
388 although large standard deviations at high CBSV levels
389 were also observed. For genotypes that showed shoot
390 symptoms, symptom expression was highly correlated
391 with at least one of the viruses (either UCBSV or CBSV)
392 with the exception of TZ/130 which had mild shoot
393 symptoms (maximum score 2), but very high relative
394 CBSV load. Thus it appears that a correlation between
395 virus load and symptom expression holds true for at
396 least one virus species in susceptible genotypes, but
397 breaks down in genotypes showing some resistance or
398 tolerance. Regarding relative virus load and root necrosis,
399 there were a number of exceptions where the correlation
400 did not hold true, and which define the ‘categories’ outlined
401 below. NASE 1, TZ/130 and to some extent AR40-6
402 appeared to allow accumulation of virus while restricting
403 symptom expression. It is important that such genotypes
404 are not distributed as varieties directly as they would serve
405 as inoculum reservoirs and accelerate virus spread. They
406 could be crossed with varieties that are able to restrict
407 virus accumulation to combine this trait with reduced
408 symptom expression. NASE 14 and NASE 19 on the other
409 hand appear to keep virus load low, but express a severity
410of root necrosis up to Class 5 with relatively high
411incidence. This apparent break in correlation indicates
412distinct resistance mechanisms that govern symptom
413expression and virus accumulation.
414Categories of disease response
415Virus resistance terminology is a contentious issue on
416which there is no general agreement and a number of
417definitions exist [33,34]. According to [33] truly resistant
418cultivars are not readily infected, even when exposed to
419large amounts of vector-borne inoculum and when
420infected they develop inconspicuous symptoms that
421are not associated with obvious deleterious effects on
422growth and yield and support low virus content and thus
423to be a poor source of inoculum. The term ‘resistance’ is
424therefore a combination of two different components:
425virus titre or load and symptom expression.
426CBSD shoot and root necrosis incidence and severity
427and relative virus load suggest that at least two main
428mechanisms may be operating, one that seems to restrict
429symptom expression under high virus load, and the
430other that seems to inhibit virus accumulation. The
431ability of some varieties to impair the replication of
432CBSVs has been observed in cassava [21,23], although
433documented cases of this in other plant species are
434rare [35,36]. Various genotypes seem to possess none,
435either one, or a combination of these mechanisms. Based
436on this, four categories of genotypes were recognized
437according to response to the CBSD viruses:
438(1) Namikonga showed resistance to field disease
439symptoms and kept virus loads low relative to the
440susceptible genotypes. Namikonga remained
441symptomless apart from one plant that showed root
442necrosis with maximum score of 2 (very minor
443discoloration). Relative virus load declined from 7 to
4449 and 11MAP for both UCBSV and CBSV
445respectively in Namikonga. This indicates an ability
446to restrict virus accumulation and resist root
447necrosis development. Based on relative virus load,
448under glasshouse conditions with graft inoculation
449‘Namikonga’ has been classified as ‘resistant’ [21]
450and our results concur with this.
451(2) This category comprises genotypes that appear to
452keep virus loads low, but express a range of
453symptoms from slightly more severe, at a slightly
454higher incidence, than Category 1 (Kiroba) to those
455that show root necrosis up to Class 5. Kiroba had an
456average root necrosis of 1.07, maximum score 3 and
457an incidence of 14.3%, but kept virus loads low. A
458decline in virus loads was observed from 7MAP for
459UCBSV, and dramatically from 9MAP for CBSV.
460Kiroba has previously been classified as ‘tolerant’ due
461to intermediate virus loads [21]. Here Kiroba has an
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462 intermediate position between Categories 1 and 2
463 but is placed in Category 2 because of a maximum
464 root necrosis score of 3. NASE 14 and NASE 19 are
465 included in this category as they kept virus loads low
466 and showed no shoot symptoms but showed root
467 necrosis up to maximum score 5. NASE 14 showed
468 a decline in CBSV and UCBSV relative virus load
469 from 7MAP, whereas in NASE 19 this decline
470 occurred from 9MAP for CBSV and relative virus
471 loads continue to rise for UCBSV albeit at extremely
472 low levels. No consistent relationship between
473 relative virus load and symptom expression was
474 observed in NASE 14 and NASE 19, although this
475 may have been obscured by pooling leaf samples
476 prior to real-time RT-PCR.
477 (3) This category comprises genotypes that harbor high
478 virus loads but show relatively mild symptoms with
479 low incidence. NASE 1 showed mild symptoms with
480 no shoot symptoms, a maximum root necrosis of 3
481 with 73.3% of plants remaining symptom free.
482 Similarly TZ/130 showed mild symptoms with 17%
483 shoot symptoms and a maximum score of 2, and a
484 mean root necrosis score of 1.2, and a maximum of
485 4. AR40-6 could also be considered in this category
486 with maximum root necrosis of score 3, and a mean
487 of 1.09, although it did show a high level of shoot
488 symptom incidence (52%) and a maximum score of
489 3. NDL06/132 also had a high incidence of shoot
490 symptoms (67%), but moderate root symptoms
491 (minimum 2, maximum 3). The four varieties did
492 harbor high levels of CBSV and thus seemed to be
493 able to restrict symptom expression to some extent
494 but not CBSV load. NDL06/132 also had a high
495 UCBSV load. This again brings into question the
496relationship between symptom expression and relative
497virus load observed by [20,21,23].
498(4) Kibaha, Albert and TME 204 were susceptible both
499in terms of field symptoms (both shoot and root
500necrosis) and virus load, having high relative virus
501loads for both UCBSV and CBSV.
502Relating these four categories to conventional termin-
503ology, Category 1 can be equated to ‘resistance’, Category 2
504can be considered ‘tolerant (restricted virus load)’, Category
5053 ‘tolerant (restricted symptom incidence and severity)’ and
506Category 4 as ‘susceptible’. It is envisioned that classifying
507genotypes in this way will not only make biological sense to
508‘field breeders’, but, by providing transparency in terms of
509symptoms and virus load, will help breeders in making
510choices of parents for crossing. For example, it may be
511prudent to cross a variety showing resistance to symptom
512expression with one showing restricted virus accumulation.
513It is worth noting that only leaf samples were used for ana-
514lysis of virus accumulation. Therefore it is possible that
515those genotypes that show reduced root necrosis (Kiroba,
516Namikonga and NASE 1) allow virus accumulation in the
517leaves but restrict the translocation of the virus to the roots.
518This requires further investigation. In addition, samples
519were pooled across plants, which obscures among plant
520variation.
521Implications for cassava breeding
522The above results indicate at least two possible mechanisms
523of resistance/tolerance to CBSVs. This is consistent with
524earlier findings. Namikonga and possibly Kiroba are direct
525derivatives of the Amani breeding program, whereas NASE
52614 and NDL06/132 have Amani breeding germplasm in
527their pedigrees (Table T55). The Amani breeding program
t5:1 Table 5 Pedigree information of varieties included in this study
t5:2 Variety Pedigree Possible source of CBSD resistance/tolerance
t5:3 Namikonga Known as ‘Kaleso’ in Kenya. Third backcross from inter-specific hybrid (46106/27)
from M. glaziovii from Amani breeding program [29,5]
M. glaziovii
t5:4 NASE 1 Introduced as TMS 60142 from IITA in early 1980s Unknown
t5:5 AR40-6 Bred by CIAT. Has 12.5% from wild species M. esculenta subsp. flavellifolia and 50%
from CMD resistant variety C39.
t5:6 Kiroba Landrace from Tanzania Unknown
t5:7 TZ/130 Selection made in Uganda from open pollinated seeds introduced from Tanzania Unknown
t5:8 NASE 14 Also known as MM96/4271. Bred by IITA.
t5:9 NASE 19 Also known as 72 TME 14. It is a half-sib of TME 14, a landrace from West Africa
introduced by IITA
Unknown
t5:10 NDL06/132 Breeding line selected at ARI Naliendele in southern Tanzania. It is an S1 self of
variety NAL 90/34 which showed strong resistance to CBSD [5] and is half sib of
Kibaha. which has M. e. subsp. flabellifolia background.
t5:11 Albert Local landrace from Tanzania Susceptible check
t5:12 Kibaha M. e. subsp. flabellifolia background.
t5:13 TME 204 Introduction from IITA. Susceptible check
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528 involved crosses with wild species, followed by up to three
529 back-cross generations and inter-crossing of backcross
530 selections. The low harvest index of Namikonga is likely
531 to be due to residual non-storage root producing wild
532 species genome.
533 The breeding strategy was likely to have resulted in
534 the combination of resistance genes from several sources
535 [5]. Inter-crossing among them would concentrate resist-
536 ance genes and allow recessive genes to be expressed
537 [5]. CBSD resistance was observed to be satisfactory in the
538 backcrosses and was maintained in the inter-crosses [18].
539 This pool of resistance factors may also have been
540 augmented by local cultivars that were unintentionally
541 selected in areas of high disease pressure for resistance/
542 tolerance to CBSD. Similarly [5] concluded that the type
543 of ‘resistance’ expressed seems to differ between cultivars.
544 They observed variations in symptoms as observed in
545 this study.
546 CBSD resistance has been reported to be quantitative
547 and recessive with both additive and non-additive
548 genetic effects [29,32]. However, the additive effects
549 were more important, implying that intra-population
550 selection methods should be effective in accumulating
551 favorable alleles in breeding materials [37]. In addition,
552 resistance to CBSD and CMD were inherited independently
553 of each other and showed continuous variation in their
554 expression.
555 This was a preliminary study to investigate virus load in
556 genotypes with contrasting symptoms under field condi-
557 tions. It was based on responses in a single growing season
558 (12 months) and thus broadening our understanding on
559 the concept of virus resistance (viral load) and disease
560 resistance (symptom expression). It is important that
561 disease observations and virus load are measured over
562 several years and across a broader range of environments.
563 Studies to identify quantitative trait loci are underway
564 to further extrapolate resistance mechanisms as are
565 differential gene expression studies based on RNASeq
566 [21] (Ferguson personal communication).
567 Conclusion
568 This study reveals a complex situation with regard to
569 resistance or tolerance to CBSD. The genotypes not only
570 showed variation in shoot and root necrosis incidence and
571 severity, but also relative virus load of UCBSV and CBSV,
572 and with time. Substantially different levels of the virus
573 species were found in many genotypes suggesting either
574 resistance to one virus species or the other, or some form
575 of interaction, antagonism or competition between virus
576 species. It appears that virus load is not always correlated
577 with symptom expression, so some genotypes are able to
578 withstand high levels of virus while showing mild
579 symptoms (NASE 1, TZ/130, AR40-6 and NDL06/132).
580 Other genotypes are able to restrict virus accumulation or
581have a system of recovery (Kiroba, NASE 14, NASE 19).
582Some genotypes may possess a combination of these
583different mechanisms (Namikonga). Historical evidence
584from the Amani breeding program, based on backcrossing
585from inter-specific crosses and inter-crossing of inter-
586specific derivatives supports the hypothesis and evidence
587for different mechanisms of resistance including those
588that restrict virus accumulation and those that restrict
589symptom expression. A substantial amount of research
590still needs to be undertaken to fully understand the bases
591of resistance. This information will be useful to plant
592breeders in informing breeding strategies and restricting
593virus spread. For durable resistance, various mechanism
594can be combined or exploited by considering both virus
595and disease resistance in different genotypes.
596Methods
597Selection and field establishment of cassava genotypes
598Eleven cassava genotypes selected from Uganda and
599Tanzania were screened for field resistance to both
600UCBSV and CBSV in Uganda. Tanzanian genotypes
601reported to be resistant/tolerant in Tanzania were AR40-6,
602NDL06/132, Kiroba and Namikonga (also known as
603Kaleso), and Ugandan genotypes reported to be tolerant in
604Uganda were NASE 14 (MM96/4271), 72-TME 14 (NASE
60519), NASE 1 and TZ/130 (Table 5). Genotypes Albert from
606Tanzania, and Kibaha and TME 204 from Uganda were
607included as susceptible controls. Genotypes from Tanzania
608were obtained as virus-free tissue culture plantlets while
609those from Uganda were sourced as stakes from CBSD
610disease-free areas. All planting material was diagnosed as
611free of (U)CBSV prior to planting. Tissue culture
612plantlets were hardened according to [38]. Field trials
613were established in the first rains (March – May) of
6142012 at National Crops Resources Research Institute
615(NaCRRI), Central Uganda (lat/lng: 0.529, 32.612, Alt
6161222 m), an area with high CBSD and whitefly pressure
617[39]. Test genotypes were established in two row unrepli-
618cated plots each containing 10 plants with a spacing of
6191 m× 1 m. Each plot was separated by a CBSV/UCBSV
620infected spreader row of TME 204. Plants of TME
621204 used in the spreader rows were obtained in fields
622that had a CBSD incidence of 100% and a mean severity
623of 4 and 4.5 for shoot and root necrosis respectively. This
624selection was done to ensure that infector line had high
625viral load to effectively augment CBSD pressure. The
626genotypes were grown for 12 months under rainfed
627conditions on a sandy-loam soil and no fertilizer or
628herbicide was applied. Regular weeding was undertaken.
629Field evaluation
630The trial was monitored for above ground symptoms
631during the crop growth period and symptoms in the
632roots after harvest. Symptoms on shoots (leaves and
Kaweesi et al. Virology Journal 2014, 11:216 Page 11 of 14
http://www.virologyj.com/content/11/1/216
633 stems) were recorded on each plant at three, five, seven
634 and nine months after planting (MAP). A severity score
635 of 1–5 [39] was adopted where 1- no apparent symptoms,
636 2- slight foliar chlorotic leaf mottle, no stem lesions,
637 3- foliar chlorotic leaf mottle and blotches with mild
638 stem lesions, no dieback, 4- foliar chlorotic leaf mottle
639 and blotches and pronounced stem lesions with no
640 dieback and 5- defoliation with stem lesions and pro-
641 nounced dieback. A mean shoot severity score was then
642 calculated per genotype based on all individual plant
643 scores per genotype at 9 MAP.
644 Severity scores for root necrosis were also taken on all
645 roots harvested per plant at 12MAP. At harvest, each
646 root was cut across into slices approximately 5 cm apart,
647 and the maximum severity score taken for each root
648 where 1- no necrosis, 2- mild necrotic lesions (1-10%),
649 3-pronounced necrotic lesions (11-25%), 4-severe nec-
650 rotic lesions (26-50%) and 5- very severe necrotic lesions
651 (>50%). A root disease severity mean value was calculated
652 on a per plant basis, and then averaged over plants to give
653 a mean value for each genotype. Per plant mean root
654 necrosis incidence was quantified as a ratio of the
655 number of roots showing root symptoms to the total
656 number of roots harvested per plant. This was averaged to
657 give a value per genotype.
658 In addition, at 12 MAP fresh shoot biomass (stems
659 and leaves) and roots per plant were weighed separately
660 and harvest index calculated on a plot basis as the ratio
661 of storage root weight to total plant biomass and storage
662 root weight [40]. This was used as an indirect assessment
663 of fresh root yield.
664 Sample collection and RNA extraction
665 At 3MAP, six plants per genotype that showed leaf
666 symptoms were tagged for leaf sampling, whereas
667 sampling of six plants of symptomless genotypes was
668 done through random selection. At 3,5,7,9 and 11
669 MAP a mature leaf (second level from the bottom) was
670 sampled from each tagged plant and stored at −84°C. At
671 the beginning of the trial, many of these genotypes did not
672 show foliar symptoms for the first 3 MAP. Leaves were
673 therefore pooled together to avoid or reduce false negative
674 probability for detection and quantification of CBSV/
675 UCBSV in cassava tissues [41] and also to reduce the cost
676 of analysis. Approximately 100 mg of leaf tissue was
677 ground into fine powder using liquid nitrogen and a small
678 hand roller. To this was added 1 ml CTAB grinding buffer
679 containing 2% CTAB, 100 mM Tris – HCl, pH 8.0,
680 20 mM EDTA and 1.4 M NaCl. This was then incubated
681 at 65°C for 15 minutes after which 700 μl of chloroform:
682 isoamyl alcohol (24:1) was added and centrifuged at
683 maximum speed in a microfuge for 10 min at room
684 temperature. The aqueous layer that formed was removed
685 and transferred into a clean nucleases free 1.5 ml microfuge
686tube after which an equal volume of 4 M LiCl was added
687and incubated overnight. The mixture was centrifuged for
68830 min at maximum speed of 13,000 g at 4°C to pellet the
689nucleic acids.
690The pellet was re-suspended in 200 μl of TE buffer
691containing 1% SDS after which 100 μl of 5 M NaCl and
692300 μl of ice cold iso-propanol was added and the mixture
693incubated at −20°C for 30 min. After incubation, the
694mixture was centrifuged for 10 min at 13,000 g to
695pellet the nucleic acid. The pellet was then washed by
696adding 500 μl of 70% ethanol and centrifuged for
6974 min at 4°C. The ethanol was decanted off and the
698pellet dried and re-suspended in 50 μl of nuclease –free
699sterile water. RNA quality and quantity was measured
700using a Nanodrop ND-1000. Due to differences in RNA
701quantity, the samples were normalized to a working
702concentration of 100 ngμl−1 by addition of an appropriate
703amount of sterile water.
704Quantitative real time PCR for CBSV and UCBSV
705The RT-PCR assay used was based on TaqMan chemistry
706using primer and probe sequences reported by [41] except
707that the CBSV probe was 5’-FAM-TAMRA-3’ labeled
708and the UCBSV probe was 5’-VIC-TAMRA-3’ labeled.
709In addition, COX (cytochrome oxidase) was used as an
710internal control with primers COX-F (5’- CGTCGCATTC
711CAGATTATCCA-3’), COX-R (5’- CAACTACGGATATA
712TAAGRRCCRRAACTG-3’) and probe (5’- [FAM]-AGGG
713CATTCCATCCAGCGTAAGCA-[TAMRA]-3)’. COX is a
714widely used housekeeping gene to normalize cycle
715threshold (Ct) values and was validated by [41] for use with
716CBSV and UCBSV quantification using real-time PCR. For
717each RNA sample, two technical replicate reactions were
718prepared containing 12.5 μl of Maxima Probe qPCR
719Master Mix (2X) (Fermentas), 7.5 μM of each forward and
720reverse primer, 5 μM Taqman probe, 100 ng of template,
721MMLV-Reverse transcriptase and nuclease free sterile
722water to volume of 25 μl. In addition, non-template water
723control was included on every plate. The reactions were
724incubated for 60 min at 42°C then initial denaturation
725step run for 10 min at 95°C followed by 40 cycles of
726denaturation for 15 sec at 95°C, annealing for 30 sec
727at 60°C and extension for 30 sec at 72°C.
728All real-time PCR reactions were performed on an
729Applied Biosystems’ One Step Plus® sequence detection
730system (Applied Biosystems). The generated cycle thresh-
731old (Ct) values were used to determine the fold change
732in expression of a target gene relative to that at
7333MAP for both CBSV and UCBSV using a compara-
734tive 2-ΔΔCt method as described by [42] where ΔΔCt =
735(Cttarget-CtCox)time x – (Cttarget-CtCox)3 months and where x
736is time (5, 7, 9, 11 MAP). All genotypes that had Ct value
737of 40 for UCBSV or CBSV were considered to be free of
738these viruses. The fold changes were transformed to log10
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739 and plotted against time (MAP) to monitor the relative
740 accumulation of virus in different genotypes with time. In
741 addition log10 fold changes were regressed against
742 mean shoot symptom scores at 3,5,7,9 and 11MAP and
743 the coefficient of determination (r2) calculated.
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